Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-jRCT2080221434
JPRN-jRCT2080221434UnknownPhase 2

M518101 phase 2b study in plaque psoriasis patients - comparison study 2

Maruho Co.,Ltd.0 sitesStarted: April 18, 2011Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 16age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • •1. Patients diagnosed with plaque psoriasis

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 1Plaque psoriasis
JPRN-jRCT2080221433Maruho Co.,Ltd.
Unknown
Phase 2
M518101 phase 2b study in plaque psoriasis patients - comparison study 3Plaque psoriasis
JPRN-jRCT2080222091Maruho Co.,Ltd.
Unknown
Phase 3
M518101 phase III study in plaque psoriasis patientsPlaque psoriasis
JPRN-jRCT2080222894Maruho Co.,Ltd.
Unknown
Phase 3
A phase III study of M801801 in plaque psoriasis patientsPlaque psoriasis
JPRN-jRCT2080222104Maruho Co.,Ltd.
Completed
Phase 3
Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque PsoriasisPsoriasis
NCT01878461Maruho North America Inc.542
M518101 phase 2b study in plaque psoriasis... | Clinical Trial